Nieto Y - Search Results

1

Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.

Nieto Y, Valdez BC, Thall PF, Jones RB, Wei W, Myers A, Hosing C, Ahmed S, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Shah N, Bashir Q, Alousi A, Oki Y, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS. Nieto Y, et al. Cancer. 2016 Sep 1;122(17):2680-8. doi: 10.1002/cncr.30100. Epub 2016 May 20. Cancer. 2016. PMID: 27203405 Free PMC article.

2

Peripheral blood stem cell harvesting and CD34-positive cell selection.

Shpall EJ, Cagnoni PJ, Bearman SI, Ross M, Nieto Y, Jones RB. Shpall EJ, et al. Among authors: nieto y. Cancer Treat Res. 1997;77:143-57. doi: 10.1007/978-1-4615-6349-5_7. Cancer Treat Res. 1997. PMID: 9071502 Review. No abstract available.

3

Standard versus high-dose therapy in 10+ breast cancer.

Nieto Y, Cagnoni PJ, Jones RB. Nieto Y, et al. J Clin Oncol. 1998 Feb;16(2):810-1. doi: 10.1200/JCO.1998.16.2.810. J Clin Oncol. 1998. PMID: 9469383 No abstract available.

4

High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.

Cagnoni PJ, Nieto Y, Shpall EJ, Bearman SI, Barón AE, Ross M, Matthes S, Dunbar SE, Jones RB. Cagnoni PJ, et al. Among authors: nieto y. J Clin Oncol. 1998 May;16(5):1661-8. doi: 10.1200/JCO.1998.16.5.1661. J Clin Oncol. 1998. PMID: 9586876

5

High-dose chemotherapy in gynecologic malignancies.

Nieto Y, Cagnoni PJ, Shpall EJ. Nieto Y, et al. Cancer Treat Res. 1998;95:277-85. doi: 10.1007/978-1-4615-5447-9_10. Cancer Treat Res. 1998. PMID: 9619289 Review. No abstract available.

6

Acute encephalopathy: a new toxicity associated with high-dose paclitaxel.

Nieto Y, Cagnoni PJ, Bearman SI, Shpall EJ, Matthes S, DeBoom T, Barón A, Jones RB. Nieto Y, et al. Clin Cancer Res. 1999 Mar;5(3):501-6. Clin Cancer Res. 1999. PMID: 10100699 Clinical Trial.

7

Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Nieto Y, Xu X, Cagnoni PJ, Matthes S, Shpall EJ, Bearman SI, Murphy J, Jones RB. Nieto Y, et al. Clin Cancer Res. 1999 Apr;5(4):747-51. Clin Cancer Res. 1999. PMID: 10213208 Clinical Trial.

8

Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer.

McNiece I, Jones R, Cagnoni P, Bearman S, Nieto Y, Shpall EJ. McNiece I, et al. Among authors: nieto y. Hematol Cell Ther. 1999 Apr;41(2):82-6. doi: 10.1007/s00282-999-0082-y. Hematol Cell Ther. 1999. PMID: 10344558 Clinical Trial.

9

Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant.

Nieto Y, Ross M, Gianani R, Shpall EJ, Cagnoni PJ, Bearman SI, Jones RB. Nieto Y, et al. Bone Marrow Transplant. 1999 Jun;23(12):1323-4. doi: 10.1038/sj.bmt.1701797. Bone Marrow Transplant. 1999. PMID: 10414924

10

Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.

Nieto Y, Cagnoni PJ, Shpall EJ, Matthes S, Barón A, Jones RB, Bearman SI. Nieto Y, et al. Clin Cancer Res. 1999 Jul;5(7):1731-7. Clin Cancer Res. 1999. PMID: 10430076 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters